Loma Linda Patient First in California to Receive a Telescope Implant for Macular Degeneration after Having Cataract Surgery

LOMA LINDA, Calif., Nov. 28, 2018 (GLOBE NEWSWIRE) — A patient at Loma Linda University Eye Institute became the first in California to receive the Miniature Implantable Telescope (By Dr. Isaac Lipshitz) for age-related macular degeneration after previously having cataract surgery. The surgery, which was part of a nationwide clinical trial, took place on October 17.

Dr. Rauser is one of only 20 eye surgeons nationwide participating in the clinical trial of the Implantable Miniature Telescope (by Dr. Isaac Lipshitz), a medical device that is already FDA approved for patients with end-stage, age-related macular degeneration (AMD) who have not yet had surgery to remove a cataract. The new trial will evaluate the safety and effectiveness of the device for patients with end-stage AMD who have already had a cataract removed from the eye that will be implanted.

Until now, the telescope implant treatment program, which is marketed under the brand name CentraSight® was only available to patients 65 and over who have not had cataract surgery, a common procedure for seniors experiencing some vision loss.

If the trial is successful, it could potentially expand the eligibility for the procedure to many more people.

Smaller than a pea, the telescope implant uses micro-optical technology to magnify images which would normally be seen in one’s straight ahead vision. The images are projected onto the healthy portion of the retina not affected by the disease, making it possible for patients to see or discern the central vision object of interest…..

Read more: https://apnews.com/f2e3be88bf7b4dc0dbc1855ad2ed21b4

Source: AP News